NASDAQ: ACHCAcadia Healthcare Company Inc Stock
$25.21+0.34 (+1.37%)
Updated Jun 22, 2026
ACHC Price
$25.21
Fair Value Price
N/A
Market Cap
$2.32B
52 Week Low
$11.43
52 Week High
$30.20
P/E
-2.07x
P/B
1.18x
P/S
0.63x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.37B
Earnings
-$1.11B
Gross Margin
34.4%
Operating Margin
-27.62%
Profit Margin
-32.8%
Debt to Equity
1.73
Operating Cash Flow
$182M
Beta
0.8
Next Earnings
Aug 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A
ACHC Overview
Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico. Patients receive care in diverse environments, including acute inpatient psychiatric hospitals, specialized treatment facilities, long-term residential centers, and outpatient clinics. As of March 31, 2022, the company managed an extensive network consisting of 238 behavioral healthcare facilities, collectively providing approximately 10,600 beds. Established in 2005, Acadia Healthcare is headquartered in Franklin, Tennessee.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ACHC's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
ACHC
Ranked#23 of 40
Ranked#23 of 40
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $23.52 | A | |
| $30.34 | A | |
| $7.92 | A |
Be the first to know about important ACHC news, forecast changes, insider trades & much more!
ACHC News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ACHC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ACHC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ACHC is good value based on its book value relative to its share price (1.18x), compared to the US Medical Care Facilities industry average (4.8x)
P/B vs Industry Valuation
ACHC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ACHC due diligence checks available for Premium users.
Valuation
ACHC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.07x
Industry
15.26x
Market
7.94x
ACHC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.18x
Industry
4.8x
ACHC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ACHC's financial health
Profit margin
Revenue
$828.8M
Net Income
$4.1M
Profit Margin
0.5%
ACHC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ACHC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.5B
Liabilities
$3.4B
Debt to equity
1.73
ACHC's short-term assets ($837.20M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACHC's long-term liabilities ($2.89B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACHC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ACHC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$61.5M
Investing
-$60.2M
Financing
$23.9M
ACHC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ACHC vs Medical Care Facility Stocks
Acadia Healthcare Company Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.